
Menbutone
CAS No. 3562-99-0
Menbutone( Menbutone | Epanaftol | Fel-Bis | Genabil | Genabilin | Membutona | Menbutonum | Naftobil | SC 1749 )
Catalog No. M14222 CAS No. 3562-99-0
Menbutone is an organic compound with fomula C15H14O4.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
100MG | 43 | In Stock |
![]() ![]() |
200MG | 61 | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameMenbutone
-
NoteResearch use only, not for human use.
-
Brief DescriptionMenbutone is an organic compound with fomula C15H14O4.
-
DescriptionMenbutone is an organic compound with fomula C15H14O4.
-
In Vitro——
-
In Vivo——
-
SynonymsMenbutone | Epanaftol | Fel-Bis | Genabil | Genabilin | Membutona | Menbutonum | Naftobil | SC 1749
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number3562-99-0
-
Formula Weight258.27
-
Molecular FormulaC15H1404
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESO=C(O)CCC(C1=C2C=CC=CC2=C(OC)C=C1)=O
-
Chemical Name4-(4-methoxynaphthalen-1-yl)-4-oxobutanoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference



-
IRBP (1-20), human
IRBP (1-20), human is the 1-20 fragment of interphotoreceptor retinoid binding protein (IRBP).This peptide is a 1 to 20 amino acid fragment of the interphotoreceptor retinoid binding protein (IRBP). IRBP is a 140-kDa glycolipoprotein residing in the interphotoreceptor matrix between the neural retina and the retinal pigment epithelium.
-
3-Methyladipic acid
3-Methyladipic acid is a metabolite of the catabolism of phytanic acid. Patients with adult Refsums disease (ARD) are unable to detoxify phytanic acid by alpha-oxidation and so the w-oxidation pathway is the only metabolic pathway available for phytanic acid degradation.
-
VT-105
VT-105 is a potent and selective TEAD autopalmitoylation inhibitor that hinders proliferation and tumor growth in NF2-deficient mesotheliomas.